99
Participants
Start Date
May 4, 2016
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Computed Tomography
Undergo PET/CT
F-18 16 Alpha-Fluoroestradiol
Given IV
Laboratory Biomarker Analysis
Correlative studies
Positron Emission Tomography
Undergo PET/CT
Mount Sinai Hospital, New York
Memorial Sloan Kettering Cancer Center, New York
University of Pennsylvania/Abramson Cancer Center, Philadelphia
Fox Chase Cancer Center, Philadelphia
Fox Chase Cancer Center - East Norriton Hospital Outpatient Center, East Norriton
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
University of Alabama at Birmingham Cancer Center, Birmingham
Vanderbilt University/Ingram Cancer Center, Nashville
Ohio State University Comprehensive Cancer Center, Columbus
Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
Sidney and Lois Eskenazi Hospital, Indianapolis
Springmill Medical Center, Indianapolis
ProHealth Oconomowoc Memorial Hospital, Oconomowoc
ProHealth D N Greenwald Center, Mukwonago
ProHealth Waukesha Memorial Hospital, Waukesha
UW Cancer Center at ProHealth Care, Waukesha
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Mayo Clinic in Rochester, Rochester
Washington University School of Medicine, St Louis
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Huntsman Cancer Institute/University of Utah, Salt Lake City
Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
City of Hope Comprehensive Cancer Center, Duarte
University of Washington Medical Center - Montlake, Seattle
National Cancer Institute (NCI)
NIH